SL Science Holding Limited Ordinary Shares

SLBTNASDAQUSD
2.08 USD
0.02 (0.95%)🟢LIVE (AS OF 11:31 AM EDT)
🟢Market: OPEN

SLBT is currently priced at $2.08. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. This is driven by a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Sep 10, 2026.

Open?$2.09
High?$2.13
Low?$2.02
Prev. Close?$2.10
Volume?20.5K
Avg. Volume?N/A
VWAP?$2.08
Bid / Ask
Bid?$2.06 × 100
Ask?$2.40 × 100
Spread?$0.34
Midpoint?$2.23
Valuation & Ratios
Market Cap?1.2B
Shares Out?N/A
Float?226.9M
Float %?40.5%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
Employees
20
Market Cap
1.2B
Industry
N/A
Listed
2026-06-15
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.02%Low
Short Interest?37.7K
Days to Cover?1.1
Free Float226.9M
Avg Daily Volume33.9K
Settlement Date2026-08-31